BASF Shares Under Pressure as Analysts Slash Forecasts

While BASF continues to promote its innovative recycling technologies and digital farming solutions, a stark warning from Berenberg analysts is shifting investor focus. The private bank has significantly downgraded its profit projections for the chemical giant through 2027, citing substantial concerns about the company’s near-term profitability. This raises serious questions about the stock’s ability to mount a meaningful recovery.

Significant Downgrades Amid Mounting Profitability Concerns

Although Berenberg maintains a ‘Hold’ rating on BASF with a price target of €44, the underlying message is decidedly cautious. The analysts see little potential for positive catalysts in the short term and have identified three primary threats to earnings:

• Persistent margin compression within the company’s typically profitable US operations
• Hesitant customer investment decisions driven by broad economic uncertainty
• Fundamental doubts over the chemical sector’s ability to achieve double-digit earnings growth by 2026

These structural issues currently overshadow any positive operational developments from the company’s Ludwigshafen headquarters.

Strategic Initiatives Fail to Offset Broader Challenges

BASF’s recent efforts to drive growth include showcasing new recycling processes for the footwear industry at a trade fair in Milan. Simultaneously, the company is expanding the reach of its digital agriculture platform, xarvio® FIELD MANAGER, into key markets like Argentina and Brazil.

Should investors sell immediately? Or is it worth buying BASF?

However, these niche successes appear insufficient to counter the powerful headwinds pressuring the company’s main profit drivers. Financial markets are largely dismissing these initiatives, concentrating instead on the fragile macroeconomic landscape and BASF’s weakened earnings power.

Technical Picture Reflects Persistent Weakness

The stock’s current price of €42.97 places it firmly below all key moving averages, highlighting a sustained negative trend. In a telling statistic, the share price remains more than 20% below its 52-week high of €53.98. A Relative Strength Index (RSI) reading of 34.7 indicates the stock is not in oversold territory but clearly underscores a complete lack of buying momentum.

The path to a sustained recovery seems challenging. With ongoing structural problems in the critical US market and continued customer reluctance to commit capital, any significant upward trend will be difficult to achieve. The analysts at Berenberg have already cast their vote.